// App-Quantinova.ai

PO0071 : Real World Data : Safety and Mortality Monitoring the patients on Rivaroxaban in our center

Researchers

Presenter

  • F. Alayoubi

Principal Investigators

  • A. Hayajneh

Medical Centers

  • KSUMC, Riyadh, Ar Riyad, Saudi Arabia

  • King Saud Univesrty, ryidh, Ar Riyad, Saudi Arabia

  • KSUMC, Liverpool, England, United Kingdom

Locations

  • Saudi Arabia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Non-valvular atrial fibrillation

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved